| Target Price | HK$3.19 |
| Price | HK$2.37 |
| Potential |
34.49%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target China Resources Medical 2027 .
The average China Resources Medical target price is HK$3.19.
This is
34.49%
register free of charge
HK$3.83
61.71%
register free of charge
HK$2.63
10.80%
register free of charge
|
|
| A rating was issued by 10 analysts: 1 Analysts recommend China Resources Medical to buy, 2 to hold and 7 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the China Resources Medical stock has an average upside potential 2027 of
34.49%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion HK$ | 10.74 | 11.29 |
| 6.89% | 5.07% | |
| EBITDA Margin | 11.74% | 12.55% |
| 21.55% | 6.87% | |
| Net Margin | 5.40% | 4.77% |
| 5.87% | 11.75% |
4 Analysts have issued a sales forecast China Resources Medical 2026 . The average China Resources Medical sales estimate is
This results in the following potential growth metrics:
4 China Resources Medical Analysts have issued a net profit forecast 2026. The average China Resources Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | 0.46 | 0.42 |
| 11.54% | 8.70% | |
| P/E | 5.70 | |
| EV/Sales | 0.26 |
4 Analysts have issued a China Resources Medical forecast for earnings per share. The average China Resources Medical EPS is
This results in the following potential growth metrics and future valuations:
China Resources Medical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


